FI952144L - Ei tyypittävissä olevan Haemphilus influenzaen puhdistettu P5 proteiini rokotteena ei tyypittävissä olevalle Haemophilus influenzae -kannalle - Google Patents

Ei tyypittävissä olevan Haemphilus influenzaen puhdistettu P5 proteiini rokotteena ei tyypittävissä olevalle Haemophilus influenzae -kannalle Download PDF

Info

Publication number: FI952144L
Authority: FI; Finland
Prior art keywords: haemophilus influenzae; typeable haemophilus; vaccine; purified; protein
Prior art date: 1994-05-05

Application number

FI952144A

Other languages

English (en)

Swedish (sv)

Other versions

FI952144A0 (fi

FI120149B (fi

Inventor

Gary W Zlotnick

Original Assignee

American Cyanamid Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-05

Filing date

1995-05-04

Publication date

1995-11-06

1995-05-04 Application filed by American Cyanamid Co filed Critical American Cyanamid Co

1995-05-04 Publication of FI952144A0 publication Critical patent/FI952144A0/fi

1995-11-06 Publication of FI952144L publication Critical patent/FI952144L/fi

2009-07-15 Application granted granted Critical

2009-07-15 Publication of FI120149B publication Critical patent/FI120149B/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Immunology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

FI952144A 1994-05-05 1995-05-04 Ei tyypittävissä olevan Haemophilus influenzaen puhdistettu P5 proteiini rokotteena ei tyypittävissä olevalle Haemophilus influenzae -kannalle FI120149B (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US21039494		1994-05-05
US08/210,394 US5770213A (en)	1994-05-05	1994-05-05	Purified nontypable haemophilus influenzae P5 protein as a vaccine for nontypable haemophilus influenzae infection

Publications (3)

Publication Number	Publication Date
FI952144A0 FI952144A0 (fi)	1995-05-04
FI952144L true FI952144L (fi)	1995-11-06
FI120149B FI120149B (fi)	2009-07-15

Family

ID=22782738

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI952144A FI120149B (fi)	1994-05-05	1995-05-04	Ei tyypittävissä olevan Haemophilus influenzaen puhdistettu P5 proteiini rokotteena ei tyypittävissä olevalle Haemophilus influenzae -kannalle

Country Status (14)

Country	Link
US (2)	US5770213A (fi)
EP (1)	EP0680765B1 (fi)
JP (2)	JP4236215B2 (fi)
KR (1)	KR100366482B1 (fi)
AT (1)	ATE356633T1 (fi)
AU (1)	AU704882B2 (fi)
CA (1)	CA2148563C (fi)
DE (1)	DE69535422T2 (fi)
DK (1)	DK0680765T3 (fi)
ES (1)	ES2282992T3 (fi)
FI (1)	FI120149B (fi)
IL (1)	IL113595A (fi)
NO (1)	NO951750L (fi)
PT (1)	PT680765E (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040126381A1 (en) *	1996-04-23	2004-07-01	Xin-Xing Gu	Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella
WO2002089839A1 (en) *	2001-05-03	2002-11-14	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Intranasal immunization with detoxified lipooligosaccharide from nontypeable haemophilus influenzae or moraxella catarrhalis
GB9812613D0 (en) *	1998-06-11	1998-08-12	Smithkline Beecham Biolog	Vaccine
US6974581B1 (en) *	1998-12-15	2005-12-13	Aventis Pasteur Limited	Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
GB9904183D0 (en) *	1999-02-24	1999-04-14	Smithkline Beecham Biolog	Novel compounds
US7101989B1 (en)	1999-07-09	2006-09-05	University Of North Carolina At Chapel Hill	DsrA protein and polynucleotides encoding the same
GB0025486D0 (en) *	2000-10-17	2000-11-29	Smithkline Beecham Biolog	Novel compounds
AU2003250673A1 (en) *	2002-07-24	2004-02-09	Id Biomedical Corporation	Polypeptides of nontypeable haemophilus influenzae
CN113198013B (zh)	2005-04-08	2024-02-20	惠氏有限责任公司	多价肺炎球菌多糖－蛋白质缀合物组合物
US7709001B2 (en)	2005-04-08	2010-05-04	Wyeth Llc	Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2009294321B2 (en)	2008-09-17	2014-02-13	Hunter Immunology Pty Ltd	Non-typeable Haemophilus influenzae vaccines and their uses
KR102409709B1 (ko)	2021-11-30	2022-06-16	박정민	케이블 접속장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5300632A (en) *	1986-11-18	1994-04-05	Research Foundation Of State University Of New York	Method for purifying an outer membrane protein of Haemophilus influenzae
US5098997A (en) *	1987-12-11	1992-03-24	Praxis Biologics, Inc.	Vaccines for Haemophilus influenzae
US5098987A (en) *	1989-07-13	1992-03-24	The United States Of America As Represented By The Secretary Of The Air Force	Crosslinkable rigid-rod benzobisazole polymer
PT699076E (pt)	1993-05-18	2003-03-31	Univ Ohio State Res Found	Vacina contra a otite media

1994
- 1994-05-05 US US08/210,394 patent/US5770213A/en not_active Ceased
1995
- 1995-05-02 DK DK95302996T patent/DK0680765T3/da active
- 1995-05-02 AT AT95302996T patent/ATE356633T1/de not_active IP Right Cessation
- 1995-05-02 EP EP95302996A patent/EP0680765B1/en not_active Expired - Lifetime
- 1995-05-02 DE DE69535422T patent/DE69535422T2/de not_active Expired - Lifetime
- 1995-05-02 PT PT95302996T patent/PT680765E/pt unknown
- 1995-05-02 ES ES95302996T patent/ES2282992T3/es not_active Expired - Lifetime
- 1995-05-02 JP JP13295495A patent/JP4236215B2/ja not_active Expired - Fee Related
- 1995-05-03 AU AU17814/95A patent/AU704882B2/en not_active Ceased
- 1995-05-03 IL IL11359595A patent/IL113595A/en not_active IP Right Cessation
- 1995-05-03 CA CA002148563A patent/CA2148563C/en not_active Expired - Fee Related
- 1995-05-04 KR KR1019950011163A patent/KR100366482B1/ko not_active IP Right Cessation
- 1995-05-04 NO NO951750A patent/NO951750L/no unknown
- 1995-05-04 FI FI952144A patent/FI120149B/fi active IP Right Grant
2000
- 2000-06-21 US US09/599,652 patent/USRE37741E1/en not_active Expired - Lifetime
2008
- 2008-10-24 JP JP2008274435A patent/JP2009051859A/ja active Pending

Also Published As

Publication number	Publication date
EP0680765A1 (en)	1995-11-08
ES2282992T3 (es)	2007-10-16
DE69535422T2 (de)	2007-12-13
KR950031108A (ko)	1995-12-18
CA2148563A1 (en)	1995-11-06
DE69535422D1 (de)	2007-04-26
FI952144A0 (fi)	1995-05-04
JP4236215B2 (ja)	2009-03-11
DK0680765T3 (da)	2007-07-02
ATE356633T1 (de)	2007-04-15
JPH08337598A (ja)	1996-12-24
IL113595A (en)	2001-05-20
JP2009051859A (ja)	2009-03-12
NO951750D0 (no)	1995-05-04
USRE37741E1 (en)	2002-06-11
KR100366482B1 (ko)	2003-08-02
EP0680765B1 (en)	2007-03-14
AU1781495A (en)	1995-11-16
AU704882B2 (en)	1999-05-06
NO951750L (no)	1995-11-06
IL113595A0 (en)	1995-08-31
FI120149B (fi)	2009-07-15
US5770213A (en)	1998-06-23
CA2148563C (en)	2008-10-07
PT680765E (pt)	2007-05-31

Publication	Publication Date	Title
FI943591L (fi)	1994-09-28	Synteettinen hemofilus-influenssa yhdistelmärokote
KR970704468A (ko)	1997-09-06	폴리에피토프 백신(polyepitope vaccines)
FI954498L (fi)	1996-03-23	Menetelmä persuolahiukkasten valmistamiseksi
DE69504071D1 (de)	1998-09-17	Turbomaschine
DE69524551D1 (de)	2002-01-24	Bläser fur ein Turbostrahltriebwerk
FI911552L (fi)	1991-09-30	Ilman esipuhdistaminen erottamista varten
FI961071A0 (fi)	1996-03-07	Menetelmä zeoliitin valmistamiseksi
DE69516377D1 (de)	2000-05-25	Lufttrennung
DE69506461D1 (de)	1999-01-21	Lufttrennung
DE69512847D1 (de)	1999-11-25	Lufttrennung
FI952144L (fi)	1995-11-06	Ei tyypittävissä olevan Haemphilus influenzaen puhdistettu P5 proteiini rokotteena ei tyypittävissä olevalle Haemophilus influenzae -kannalle
DE69503095D1 (de)	1998-07-30	Lufttrennung
FI964786L (fi)	1997-01-29	Menetelmä polyhydroksialkanoaattien talteenottamiseksi käyttäen ilmaluokitusta
FI962866L (fi)	1996-07-16	Menetelmä S(+)-ibuprofeeni-partikkeleiden valmistamiseksi
FI964785L (fi)	1997-01-29	Menetelmä polyhydroksialkanoaattien talteenottamiseksi käyttäen keskipakofraktiointia
FI972030L (fi)	1997-05-13	Puhdistettuja papillomavirusproteiineja
FI972720A0 (fi)	1997-06-24	Menetelmä lamotrigiinin valmistamiseksi
FI972065L (fi)	1997-05-14	Menetelmä N-fosfonometyyliglysiinin valmistamiseksi
DK0736605T3 (da)	2003-04-22	Fremgangsmåde til fremstilling af proteiner
FI964410L (fi)	1996-11-01	Menetelmä 4-amino-delta4-3-ketosteroidien valmistamiseksi 4-nitro-delta4-3-ketosteroidien kautta
FI940846L (fi)	1995-08-24	Menetelmä heraproteiinien eristämiseksi
FI965229L (fi)	1997-02-27	Menetelmä syklisten laktaamien valmistamiseksi
FI972694L (fi)	1997-06-23	Uusi menetelmä sameridiinin valmistamiseksi
FI942338L (fi)	1995-11-21	Menetelmä epäpuhtaan alumiinioksidin puhdistamiseksi uuttamalla
EP0710903A4 (en)	1997-07-02	SYSTEM FOR EDITING A SEQUENTIAL PROGRAM

Legal Events

Date	Code	Title	Description
2009-07-15	FG	Patent granted	Ref document number: 120149 Country of ref document: FI

Date

Code

Title

Description

2009-07-15

Patent granted

Ref document number: 120149

Country of ref document: FI